W R Waud - JoVE Visualize

Showing results (11-20 of 41) with videos related to

Pageof 5

Sort By:

Investigational New Drugs|January 1, 1995

Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere)D J Dykes, M C Bissery, S D Harrison, et al.

Cancer Chemotherapy and Pharmacology|January 11, 1992

Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147W R Waud, S D Harrison, C G Temple, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1996

Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemiasW R Waud, K S Gilbert, G B Grindey, et al.

Cancer Research|April 15, 1991

Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brainS D Harrison, J Plowman, D J Dykes, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1990

Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivoS D Harrison, J Plowman, D J Dykes, et al.

Cancer Gene Therapy|March 12, 2011

Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylaseW B Parker, P W Allan, W R Waud, et al.

Cancer Chemotherapy and Pharmacology|January 11, 1991

Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemiaW R Waud, S D Harrison, K S Gilbert, et al.

Cancer Research|March 15, 1987

Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosisB J Bowdon, W R Waud, G P Wheeler, et al.

Cancer Chemotherapy and Pharmacology|August 8, 2001

Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolites of penclomedineR F Struck, A Tiwari, H S Friedman, et al.

European Journal of Cancer (Oxford, England : 1990)|August 17, 1999

Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenograftsB T Hill, H H Fiebig, W R Waud, et al.

Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:

Pageof 5

Investigational New Drugs|January 1, 1995

Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere)D J Dykes, M C Bissery, S D Harrison, et al.

Cancer Chemotherapy and Pharmacology|January 11, 1992

Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147W R Waud, S D Harrison, C G Temple, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1996

Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemiasW R Waud, K S Gilbert, G B Grindey, et al.

Cancer Research|April 15, 1991

Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brainS D Harrison, J Plowman, D J Dykes, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1990

Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivoS D Harrison, J Plowman, D J Dykes, et al.

Cancer Gene Therapy|March 12, 2011

Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylaseW B Parker, P W Allan, W R Waud, et al.

Cancer Chemotherapy and Pharmacology|January 11, 1991

Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemiaW R Waud, S D Harrison, K S Gilbert, et al.

Cancer Research|March 15, 1987

Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosisB J Bowdon, W R Waud, G P Wheeler, et al.

Cancer Chemotherapy and Pharmacology|August 8, 2001

Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolites of penclomedineR F Struck, A Tiwari, H S Friedman, et al.

European Journal of Cancer (Oxford, England : 1990)|August 17, 1999

Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenograftsB T Hill, H H Fiebig, W R Waud, et al.

Pageof 5